COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,248 Articles (22,733 medRxiv, 8,515 bioRxiv)

Most recent first Previous |  Page 2461: Articles 24601-24610  | Next

Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model
Woo, S. H., Rios-Diaz, A. J., Kubey, A. A., Cheney-Peters, D. R., Ackermann, L. L., Chalikonda, D. M., Venkataraman, C. M., Riley, J. M., Baram, M.
10.1101/2020.07.16.20155739 — Posted: 2020-07-18
Association between consumption of vegetables and COVID-19 mortality at a country level in Europe
Fonseca, S. C., Rivas, I., Romaguera, D., Quijal-Zamorano, M., Czarlewski, W., Vidal, A., Fonseca, J. A., Ballester, J., Anto, J. M., Basagana, X., Cunha, L. M., Bousquet, J.
10.1101/2020.07.17.20155846 — Posted: 2020-07-18 Discussion: Onsite | Offsite
SARS-Cov-2 cysteine-like protease (Mpro) is immunogenic and can be detected in serum and saliva of COVID-19-seropositive individuals
Martinez-Fleta, P., Alfranca, A., Gonzalez-Alvaro, I., Casasnovas, J. M., Fernandez Soto, D., Esteso, G., Caceres-Martell, Y., Gardeta, S., Prat, S., Mateu-Alberoa, T., Gabrie, L., Lopez-Granados, E., Sanchez-Madrid, F., Rodriguez-Frade, J. M., Reyburn, H. T., Vales-Gomez, M.
10.1101/2020.07.16.20155853 — Posted: 2020-07-18
Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan
Yokoyama, R., Kurano, M., Morita, Y., Shimura, T., Nakano, Y., Qian, C., Xia, F., He, F., Kishi, Y., Okada, J., Yoshikawa, N., Nagura, Y., Okazaki, H., Moriya, K., Seto, Y., Kodama, T., Yatomi, Y.
10.1101/2020.07.16.20155796 — Posted: 2020-07-18
Effect of corticosteroid treatment on 1376 hospitalized COVID-19 patients. A cohort study.
Albani, F., Fusina, F., Granato, E., Capotosto, C., Ceracchi, C., Gargaruti, R., Santangelo, G., Schiavone, L., Taranto, M. S., Tosati, C., Vavassori, E., Natalini, G.
10.1101/2020.07.17.20155994 — Posted: 2020-07-18
Barriers to online learning in the time of COVID-19: A national survey of medical students in the Philippines
Baticulon, R. E., Alberto, N. R. I., Baron, M. B. C., Mabulay, R. E. C., Rizada, L. G. T., Sy, J. J., Tiu, C. J. S., Clarion, C. A., Reyes, J. C. B.
10.1101/2020.07.16.20155747 — Posted: 2020-07-18 Discussion: Onsite
Vinegar and Its Active Component Acetic Acid Inhibit SARS-CoV-2 Infection In Vitro and Ex Vivo
Pagani, I., Ghezzi, S., Clementi, M., Poli, G., Bussi, M., Pianta, L., Trimarchi, M., Vicenzi, E.
10.1101/2020.07.08.193193 — Posted: 2020-07-17
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening
Zhu, W., Xu, M., Chen, C. Z., Guo, H., Shen, M., Hu, X., Shinn, P., Klumpp-Thomas, C., Michael, S. G., Zheng, W.
10.1101/2020.07.17.207019 — Posted: 2020-07-17 Discussion: Onsite
Modeling the Impact of Lock-down on COVID-19 Spread in Malaysia
Altahir, A. A., Mathur, N., Thiruchelvam, L., Abro, G. E. M., Radzi, S. S. M., Dass, S. C., Gill, B. S., Sebastian, P., Zulkifli, S. A., Asirvadam, V. S.
10.1101/2020.07.17.208371 — Posted: 2020-07-17
SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts
Chirathaworn, C., Sripramote, M., Chalongviriyalert, P., Jirajariyavej, S., Kiatpanabhikul, P., Saiyarin, J., Soudon, C., Thienfaidee, O., Palakawong Na Ayuthaya, T., Brukesawan, C., Chaiwanichsiri, D., Intharasongkroh, D., Wanlapakorn, N., Chansaenroj, J., Puenpa, J., Yorsaeng, R., Thitithanyanont, A., Kitphati, R., Mungaomklang, A., Nagavajara, P., Poovorawan, Y.
10.1101/2020.07.17.208439 — Posted: 2020-07-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).